Authors:
Siltberg, H
Larsson, G
Hallen, B
Johansson, C
Ulmsten, U
Citation: H. Siltberg et al., Validation of cough-induced leak point pressure measurement in the evaluation of pharmacological treatment of stress incontinence, NEUROUROL U, 18(6), 1999, pp. 591-602
Authors:
Brynne, N
Svanstrom, C
Aberg-Wistedt, A
Hallen, B
Bertilsson, L
Citation: N. Brynne et al., Fluoxetine inhibits the metabolism of tolterodin-pharmacokinetic implications and proposed clinical relevance, BR J CL PH, 48(4), 1999, pp. 553-563
Authors:
Brynne, N
Forslund, C
Hallen, B
Gustafsson, LL
Bertilsson, L
Citation: N. Brynne et al., Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity, BR J CL PH, 48(4), 1999, pp. 564-572
Authors:
Brynne, N
Bottiger, Y
Hallen, B
Bertilsson, L
Citation: N. Brynne et al., Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole, BR J CL PH, 47(2), 1999, pp. 145-150
Citation: G. Larsson et al., Tolterodine in the treatment of overactive bladder: Analysis of the pooledPhase II efficacy and safety data, UROLOGY, 53(5), 1999, pp. 990-998